Telomir Pharmaceuticals (TELO) Stock Chart & Stock Price History → [URGENT] DO NOT Touch These AI Stocks! (From Weiss Ratings) (Ad) Free TELO Stock Alerts $6.91 +0.37 (+5.66%) (As of 05/10/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsSocial Media Telomir Pharmaceuticals Stock Price Performance5 Day Performance+11.45%1 Month Performance-10.14%3 Month Performance+38.20% Receive TELO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here TELO Stock Chart for Saturday, May, 11, 2024 TELO Chart by TradingView Telomir Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/09/2024$5.93$6.54+10.29%$6.78$6.0573,236 shs$193.65 million05/08/2024$6.28$5.93-5.57%$6.34$5.9326,802 shs$175.59 million05/07/2024$6.05$6.28+3.80%$6.43$6.0724,406 shs$185.95 million05/06/2024$6.20$6.05-2.42%$6.85$6.0031,444 shs$179.14 million05/03/2024$6.84$6.18-9.65%$6.63$6.0314,954 shs$182.99 million05/02/2024$6.82$6.84+0.29%$6.84$6.423,578 shs$202.53 million Get the Latest News and Ratings for TELO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/01/2024$6.62$6.82+3.02%$6.82$6.255,528 shs$201.94 million04/30/2024$7.18$6.62-7.80%$7.27$6.1711,096 shs$196.02 million04/29/2024$6.87$7.18+4.59%$7.44$6.4919,764 shs$212.60 million04/26/2024$6.80$6.86+0.88%$6.86$5.9023,964 shs$203.13 million04/25/2024$6.97$6.80-2.44%$6.97$6.519,254 shs$201.35 million04/24/2024$5.82$6.97+19.76%$6.97$5.9240,897 shs$206.38 million04/23/2024$5.61$5.82+3.84%$5.94$5.5626,229 shs$172.33 million04/22/2024$7.99$5.61-29.81%$8.32$5.50133,336 shs$165.96 million04/19/2024$7.95$7.99+0.50%$8.35$7.6632,960 shs$236.58 million04/18/2024$8.48$7.95-6.25%$8.35$7.9136,706 shs$235.40 million04/17/2024$8.37$8.48+1.31%$8.89$8.1563,652 shs$251.09 million04/16/2024$8.84$8.37-5.32%$9.39$7.77283,665 shs$247.84 million04/15/2024$9.00$8.84-1.78%$9.28$8.6957,643 shs$261.75 million04/12/2024$8.20$9.00+9.76%$9.29$7.71209,656 shs$266.49 million04/11/2024$7.69$8.20+6.63%$8.21$7.0738,448 shs$242.80 million04/10/2024$6.85$7.69+12.26%$7.76$7.0016,481 shs$227.70 million04/09/2024$6.71$6.85+2.09%$7.24$6.5113,827 shs$202.83 million04/08/2024$7.10$6.71-5.49%$7.62$6.2618,929 shs$198.68 million04/05/2024$7.31$7.00-4.24%$7.99$7.0042,582 shs$207.27 million04/04/2024$5.55$7.31+31.71%$7.56$5.2871,872 shs$216.45 million04/03/2024$5.49$5.55+1.09%$5.74$5.3016,167 shs$164.34 million04/02/2024$5.46$5.49+0.55%$5.71$5.0527,972 shs$162.56 million04/01/2024$5.15$5.46+6.02%$5.78$5.0520,000 shs$161.67 million03/29/2024$5.15$5.15$5.99$5.0030,290 shs$152.49 million03/28/2024$5.09$5.15+1.28%$5.99$5.0030,290 shs$152.49 million03/27/2024$5.56$5.09-8.54%$6.00$4.7652,512 shs$150.57 million03/26/2024$5.55$5.56+0.18%$5.93$5.3611,931 shs$164.63 million03/25/2024$6.49$5.55-14.48%$6.12$5.5517,641 shs$164.34 million03/22/2024$6.75$6.49-3.85%$6.85$6.1028,327 shs$192.17 million03/21/2024$6.60$6.75+2.27%$6.94$6.0038,053 shs$199.87 million03/20/2024$5.95$6.60+10.92%$6.91$6.0327,728 shs$195.43 million03/19/2024$4.83$5.95+23.19%$5.95$4.7623,865 shs$176.18 million03/18/2024$5.73$4.83-15.71%$6.20$4.7664,487 shs$143.02 million03/15/2024$6.51$5.73-11.98%$6.76$5.7353,292 shs$169.67 millionThe Crypto 9-5 Escape Plan (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide03/14/2024$7.22$6.51-9.83%$8.48$5.81104,726 shs$192.76 million03/13/2024$6.63$7.22+8.90%$8.37$5.6075,609 shs$213.78 million03/12/2024$6.87$6.63-3.49%$7.96$6.5420,845 shs$196.31 million03/11/2024$8.46$6.87-18.79%$8.55$6.6645,177 shs$203.42 million03/08/2024$8.70$8.46-2.76%$8.98$8.3023,543 shs$250.50 million03/07/2024$8.76$8.70-0.68%$9.00$8.5434,631 shs$257.61 million03/06/2024$8.89$8.76-1.46%$9.00$8.1152,778 shs$259.38 million03/05/2024$9.00$8.89-1.22%$9.00$8.3562,073 shs$263.23 million03/04/2024$9.05$9.00-0.55%$9.09$8.6372,459 shs$266.49 million03/01/2024$9.07$9.05-0.22%$9.20$8.70130,873 shs$267.97 million02/29/2024$8.94$9.07+1.45%$9.34$8.6049,202 shs$268.56 million02/28/2024$8.95$8.94-0.11%$9.00$8.6043,912 shs$264.71 million02/27/2024$9.06$8.95-1.21%$9.01$8.6529,322 shs$265.01 million02/26/2024$9.14$9.06-0.88%$9.44$8.7089,174 shs$268.27 million02/23/2024$8.91$9.14+2.58%$9.54$8.6653,293 shs$270.64 million02/22/2024$8.66$8.91+2.89%$9.00$8.486,861 shs$263.83 million02/21/2024$9.00$8.66-3.78%$9.00$7.7921,959 shs$256.42 million02/20/2024$9.02$9.00-0.22%$11.20$8.4782,615 shs$266.49 million02/19/2024$9.02$9.02$9.27$7.46143,400 shs$267.08 million02/16/2024$8.06$9.02+11.91%$9.28$7.46142,885 shs$0.0002/15/2024$11.90$8.06-32.27%$9.85$7.5383,276 shs$0.0002/14/2024$7.01$11.90+69.76%$20.72$7.02641,262 shs$0.0002/13/2024$6.25$7.01+12.16%$7.10$5.7839,954 shs$0.0002/12/2024$5.00$6.25+25.00%$7.00$5.0179,254 shs$0.00 Related Companies: Lifecore Biomedical Stock Price Chart Veru Stock Price Chart Galectin Therapeutics Stock Price Chart Acrivon Therapeutics Stock Price Chart Organigram Stock Price Chart Trevi Therapeutics Stock Price Chart Omeros Stock Price Chart Greenwich LifeSciences Stock Price Chart Rigel Pharmaceuticals Stock Price Chart Alimera Sciences Stock Price Chart Receive TELO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TELO) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHow Biden has already won 2024Porter & CompanyRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telomir Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.